David Lalloo

29PUBLICATIONS
163CO-AUTHORS
Medical virologyMedical infection agents (incl. prions)Pharmaceutical delivery technologiesToxicology (incl. clinical toxicology)Optometry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jun 16, 2026
A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection.

|May 15, 2026
Ophthalmic features of HIV associated cryptococcal meningitis in Malawian Adults: an observational study.

|Mar 18, 2026
Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID-19: A Dose-Escalating, Randomized Controlled Phase Ib Study.

Tim Rowland, Richard FitzGerald, Elizabeth Challenger

|Oct 21, 2025
Scorpion sting: a narrative review and proposed guidelines for contemporary UK armed forces operations.

Daniel Wilkins, S Jc Pallett, J Potter

|Sep 05, 2025
Economic burden and cost-effectiveness of treatments for open tibia fractures in Malawi: Economic analysis of a multicentre prospective cohort study.

Alexander Thomas Schade, Linda Alinafe Sande, Ewan Tomeny

|Apr 24, 2025
Relative Contribution of Pharmacokinetics and Immune Signatures to Clinical Outcomes in Patients With HIV-associated Cryptococcal Meningitis.

Katharine E Stott, Dumizulu Tembo, Cheusisime Kajanga

Pageof 5

Frequent Collaborators

5 joint publications

Peter MacPherson

3 joint publications

Dileepa Senajith Ediriweera

3 joint publications

Michael Abouyannis

3 joint publications

Hendran Maheswaran